Exalys Overview
- Year Founded
-
2018

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Exalys General Information
Description
Developer of novel anti-inflammatory therapeutics designed for the treatment of inflammatory disorders including pain and renal dysfunction. The company is focused on the development of first-in-class therapies for the treatment of inflammatory disorders with an initial target indication of the prevention of postoperative delirium, providing patients with an effective treatment for serious and potentially life-threatening conditions which have limited treatment options.
Contact Information
Website
www.exalystx.comCorporate Office
- 44 Tehama Street
- San Francisco, CA 94105
- United States
Corporate Office
- 44 Tehama Street
- San Francisco, CA 94105
- United States
Exalys Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 07-Nov-2022 | Completed | Out of Business | |||
1. Early Stage VC (Series A) | 16-Jul-2020 | Completed | Generating Revenue |
Exalys Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
Exalys Comparisons
Industry
Financing
Details
Exalys Competitors (1)
One of Exalys’s competitors is Laurent Pharma, a Venture Capital-Backed company based in Montreal, Canada.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Laurent Pharma | Venture Capital-Backed | Montreal, Canada |
Exalys FAQs
-
When was Exalys founded?
Exalys was founded in 2018.
-
Where is Exalys headquartered?
Exalys is headquartered in San Francisco, CA.
-
What industry is Exalys in?
Exalys’s primary industry is Drug Discovery.
-
Is Exalys a private or public company?
Exalys is a Private company.
-
What is Exalys’s current revenue?
The current revenue for Exalys is
. -
How much funding has Exalys raised over time?
Exalys has raised $15M.
-
Who are Exalys’s competitors?
Laurent Pharma is a competitor of Exalys.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »